Pyxis Oncology Inc expected to post a loss of 32 cents a share - Earnings Preview

Pyxis Oncology

09/08/2024 17:39

* Pyxis Oncology Inc  PYXS.OQ   PYXS.O  is expected to show
no
change in quarterly revenue when it reports  results on August
11 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Pyxis Oncology Inc is
for a
loss of 32 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pyxis
Oncology
Inc is $9.00​, above​ its last closing price of $3.48. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.21       -0.24      -0.06     Beat    75.2
 Dec. 31 2024  -0.48       -0.47      -0.33     Beat    30.5
 Jan. 1 0001   -0.49       -0.51      -0.56     Missed  -10.5​
 Jun. 30 2023  -0.64       -0.65      -0.41     Beat    36.7
 ​​Mar.        -0.90       -0.90      -0.55     Beat    38.8
 31 2023                                                
 Dec. 31 2022              -0.93      -1.01     Missed  -8.7​
 Sep. 30 2022  -0.81       -0.81      -0.85     Missed  -4.5
 Jun. 30 2022  -0.75       -0.76      -0.79     Missed  -3.7
 This summary was machine generated August 9 at 16:39 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)